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Background: Metabolic syndrome and co-morbid physical health conditions are
highly prevalent in people with a mental illness. Modifiable lifestyle factors have been
targeted to improve health outcomes. Healthy Body Healthy Mind (HBHM) program
was developed to provide an integrated evidence-based program incorporating practical
diet and exercise instruction; alongside meditation and mindfulness strategies, and
comprehensive psychoeducation, to improve the physical and mental health of those
with a mental illness.
Methods: We report on two data points: (1) Qualitative data derived from the first HBHM
program (version 1) exploring its utility and acceptance according to patient feedback;
(2) Biometric and mental health data collected on the modified and enhanced 12-week
HBHM program (version 2) involving a pilot of 10 participants. Mental and physical
health outcomes, weight, abdominal circumference, fasting glucose, cholesterol, and
triglycerides were measured at program entry and completion.
Results: Qualitative data from HBHM version 1 provided valuable feedback to redevelop
and enhance the program. At the end of the HBHM (version 2) 12-week program, a
significant mean weight loss of 2 kg was achieved, p= 0.023. There was also a significant
reduction in abdominal circumference (mean= 2.55 cm) and a decrease in BMI of almost
one point (mean = 0.96 kg/m2), p = 0.046 and p = 0.019, respectively. There were no
significant changes in mental health measures or on any other biometrics.
Conclusion: Pilot data from the HBHM program found significant reductions in weight
and abdominal obesity. The HBHM program could benefit from further modifications, and
study replication is required using a controlled design in a larger sample.
Keywords: healthy lifestyles, lifestyle medicine, metabolic syndrome, depression, program development
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INTRODUCTION
A highly complex relationship exists between physical and
mental health. The rates of physical morbidity and mortality
in people with mental illness is substantially higher than the
general population (1, 2). Even in countries with adequate
health care systems, the mortality gap is on the rise, up to a
difference of 20 years (3). Obesity and related conditions such
as cardiovascular disease, hyperlipidaemia, and diabetes mellitus
are highly prevalent in people with mental illness (4).
The cluster of symptoms associated with these lifestyle
diseases such as, excess visceral fat, along with hypertension,
glucose intolerance/insulin resistance, and/or hyperlipidaemia
has been labeled Metabolic Syndrome (MetS). In mental health
populations, the rate of MetS is thought to be between 41 and
67% (5). A large proportion of the physical health burden in
patients with a mental illness can be linked to side effects of
second generation antipsychotics, lifestyle factors (e.g., higher
rates of smoking, low levels of exercise), and factors associated
with socioeconomic disadvantage (e.g., poverty and lack of
access to nutritious foods) (6). Weight gain can result in
lowered self-esteem, impaired body-image, and reduced social
interactions, which can ultimately lead to poorer mental health
(7). Furthermore, it is also a common cause of medication non-
adherence, which can lead to illness relapse, hospitalization, and
poorer outcomes (7, 8).
There is potential to modify lifestyle factors that contribute to
MetS (e.g., caloric intake, physical activity levels, sleep hygiene)
to improve the health and well-being of people with a mental
illness. There are calls for an integrated response involving
early diagnosis, treatment and management of physical and
mental health via lifestyle modification (9). Several lifestyle-based
programs have been developed to modify the lifestyle factors
contributing to MetS (10). These programs typically focus on
exercise and nutrition for metabolic issues and result in minimal
weight loss and modest effects on well-being (10). In one review
of lifestyle interventions in adults with a serious mental illness at
risk of MetS, few programs incorporated behavioral components
such as stress management and motivation alongside exercise
and/or nutrition interventions (10). Thus, programs that target
both mental and physical outcomes in patients who are taking
psychotropic medication have not been adequately developed.
Further, previous programs often do not provide a truly
“integrative” model, tending to focus on nutrition and exercise
without incorporating components that may improve general
health and well-being (10).
To bridge the gap and provide an evidence-based integrated
health approach, we developed the “Healthy Body, Healthy
Mind Program (HBHM).” The aim was to assist people with a
diagnosed mental illness and metabolic syndrome to improve
mental and physical well-being. We presently report on: (1)
Qualitative data derived from our first version of the HBHM
program in 2011, exploring its utility and acceptance according
to patient and clinician feedback; (2) Biometric data and
mental health data collected on the modified and enhanced 12-
week, second version of HBHM program involving a pilot of
10 participants.
TABLE 1 | Metabolic syndrome clinical diagnosis guidelines*.
Measure Categorical cut point
Elevated waist circumference
(European/North American)
≥ 102 cm for men, ≥ 88 cm for
women
Elevated triglyceride levels (or drug
treatment for elevated triglycerides)
≥1.7 mmol/L
Reduced HDL-C (or drug treatment
for reduced HDL-C)
<1.0 mmol/L in men, <1.3
mmol/L in women
Elevated blood pressure (or drug
treatment for hypertension)
≥130 systolic or ≥85 diastolic
Elevated fasting glucose (or drug
treatment for elevated glucose)
>5.5 mmol/L
For a diagnosis of Metabolic Syndrome, an individual must meet three of the five specified
criteria. *As per the International Diabetes Federation Task Force on Epidemiology and
Prevention; National Heart Lunch and Blood Institute; American Heart Association; World
Heart Federation; International Atherosclerosis Society; and International Association for
the Study of Obesity (11).
MATERIALS AND METHODS
Setting And Overview
The Melbourne Clinic in Melbourne, Australia is a private
psychiatric hospital with inpatient and outpatient services.
The clinic had a longstanding weight management and
lifestyle program, called Healthy Body Healthy Mind (HBHM),
developed and facilitated by a general practitioner (GP), exercise
physiologist and dietitian. HBHM program (version 1) provided
weekly nutritional support from a dietitian, psychoeducation
sessions on lifestyle modification and exercise practicals with an
exercise physiologist. In late 2011, ethics approval was granted
by The Melbourne Clinic Research Ethics Committee (HREC
project number: 209) to collect qualitative data from participants
to evaluate the perceived efficacy of the program’s content,
barriers in implementing the components, and feedback on how
it could be improved. The qualitative data collected during 2011–
2012 was used to redevelop and enhance the integrated lifestyle
program which was pilot-tested at The Melbourne Clinic in 2016
(HREC project number: 249). This modified second programwill
henceforth be labeled as HBHM program (version 2).
Recruitment
Patients attending The Melbourne Clinic outpatient services
were invited to attend the program via a doctor’s referral.
Patients with a diagnosed mental illness (e.g., Major Depressive
Disorder, Bipolar Disorder; or with multiple diagnoses) taking
stable psychotropic medication (same dose for at least 4 weeks)
with co-morbid diagnosed metabolic syndrome (see Table 1) or
obesity (defined as a BMI of >30 OR abdominal circumference
of >80 cm for women and >94 cm for men) were the target
participants for the program. Written informed consent was
obtained from all participants to evaluate the two versions of
the program.
HBHM Version 2 (2016) Measures
At week 0, a range of medical and demographic information was
collected including, age, gender, employment status, medication
information, psychiatric diagnosis and medical co-morbidity.
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At week 0 and week 12, participants also had anthropometric
measurements taken by an exercise physiologist (BP, height,
weight, abdominal circumference) and completed self-report
questionnaires on their mental health (Depression Anxiety Stress
Scales—DASS-21). In addition at week 0, participants were asked
to state their goals for the program and what they hoped to
achieve. They were also asked to rate their readiness to change in
order to achieve their listed goals on a scale of 1–10 with 1 being
“not ready” and 10 being “ready.” Participants were provided
with a blood test request form to have fasting cholesterol, glucose
and triglyceridesmeasured at week 0 andweek 12. The blood tests
were conducted by Australian Clinical Labs.
Depression Anxiety Stress Scales—DASS-21
The DASS-21 is a self-reported screening instrument used to
measure depression, anxiety and stress symptomatology (12).
It consists of 21-items, across three scales, which measure
symptoms of depression (7 items), anxiety (7 items), and stress
(7 items). Individuals are asked to respond to each item on a
four-point Likert scale (0 = not at all to 3 = very much or
most of the time). Higher scores on each scale are indicative
of greater symptom severity. Scores above 11 (depression), 8
(anxiety), and 13 (stress) are considered severe, as indicated by
the recommended cut-offs (12).
Statistics
Qualitative data assessing the 2011 HBHM Program (version
1) was analyzed from written participant feedback forms.
Comments were coded and grouped in categories by theme
(beneficial/useful content, barriers to implementation and
program improvements) and counted to obtain a frequency of
mention by the 12 participants. For the quantitative data from the
2016 HBHM program (version 2), paired t-tests and Pearson’s r
correlations were used to compare the repeated measurements of
the sample (week 0 vs. week 12). All data was analyzed in SPSS
24. An alpha level of <0.05 was used to determine significance.
RESULTS
HBHM Version 1 (2011)—Qualitative Data
Written qualitative data from 12 participants (83% female; mean
age 43.4 years old) who participated in the first version of the
HBHM program during 2011–2012 was thematically analyzed
to aid the development of the 2016 HBHM program. Table 2
summaries the qualitative data on the early program.
The most beneficial/useful components of the program
reported by the majority of participants were the cooking and
exercise practicals (n = 11; 91%). One participant commented
that he/she needed “practical examples that can be implemented
in day-to-day life” and less theory in order to engage with the
program. However, many participants (n = 9; 75%) commented
that furthering their knowledge on how food effects the body
and the harms of nutritionally poor food and no exercise on the
body’s functioning was useful as, “understanding aids motivation
to change, oversimplification does not.” Poor motivation (n = 4;
33%), fear of change (n = 3; 25%) and difficulties engaging with
the program due to low mood and anxiety (n = 8; 66.7%) were
TABLE 2 | Qualitative feedback from HBHM (version 1).
Beneficial/useful
content
• Cooking practicals
• Hands-on experience
• Meal planning with simple and practical recipes
• Templates for shopping/organizing pantry
• Providing alternative foods to swap out “bad” foods
• Label reading and understanding ratios of good fats,
proteins and hidden sugars
• More understanding of the psychological underpinnings on
“why I eat” and overeating
• Exercise class
• Chair exercises
• Fresh air/park exercises
• Information about benefits of varying exercise
• Further knowledge on
• Certain foods and their effects on the body (e.g., what
sugar does to the body, proteins, good fats etc.)
• The harms of poor eating and no exercise on body
mechanisms
• Cravings and how to beat them
• Reminders of program schedule and encouragement to
attend
• Sharing experiences and “wins” with peers
Barriers • Unable to concentrate/absorb content/participate fully
because of low mood/anxiety
• Injury/pain and physical health issues make exercise difficult
or impossible
• Poor motivation/discipline and difficulty getting started and
maintaining momentum
• Fear of change or not ready to make changes
• Cooking for one person too hard or can’t be bothered
• Changing the eating patterns of the entire household
Program
lessons
• Provide notes at each session rather than at the
following week
• Provide diagrams of exercises to do at home
• Not enough practical cooking/exercise classes
• Group size too big with new people coming in every week
common among participants. Additionally, many participants
found cooking for one person and/or maintaining momentum
on their own difficult (n = 4; 33%). As one person stated, “[the]
desire to try a new recipe is high at time of session but then
lost when at home.” Participants requested more diagram-based
notes of exercises/recipes and program content to be accessible
at home due to poor recall (n = 3; 25%). Injury and co-morbid
physical health problems were some of the main barriers in
adding exercise to their day-to-day lives (n=8; 66.67%). At home
chair-based exercises and information on how and why to vary
exercise was deemed helpful (n= 4; 33.3%).
HBHM Version 2 (2016)—Program
Development
Based on the qualitative data detailed above, the HBHM program
in 2016 was remodeled and refined in consultation with a team
of experts in the fields of psychiatry, endocrinology/cardiology,
nutrition and dietetics, and exercise physiology. The program
was designed to integrate five evidence-based components:
lifestyle psychoeducation (13), exercise (theory and practicals)
(14), diet and nutrition (theory and practical skills e.g., cooking
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TABLE 3 | Example HBHM (version 2) practical components and education sessions.
Diet and nutrition Exercise Motivation and goal
setting
Meditation and
mindfulness
Psychoeducation
Practical
components
- Cooking
demonstrations
- Excursion to
supermarket for
healthy shopping tips
- Food label reading
- Chair based
exercises to increase
strength
- Pilates
- Yoga and stretching
- Body weight
exercises
- Interval, circuit and
resistance training
- Goal setting
- Ongoing review of
personal goals
throughout
the program
- Meditation to
improve sleep
- Mindfulness for
reducing and
managing stress
- Mindfulness
for self-compassion
N.A
Education
session topics
- Why diets don’t
work?
- Sugar—myths and
realities
- Exploring
macronutrients in
foods—protein, fats
and carbohydrates
- Benefits of physical
exercise
- The benefits of
“greenexercise”
(exercising in nature)
- Incidental exercise
strategies for
everyday life
- Ways to plan realistic
and attainable
goals—SMART goal
setting
- Finding
Motivation—the
motivation matrix
- Dealing with
setbacks and the
transtheoretical
model of change
- What are the benefits
of mindfulness
meditation?
- Mindful eating for
weight loss
and well-being
- What is the link between mental
and cardiovascular health?
- The “brain-gut” connection
and its influence on mental &
cardiovascular health
The importance of sleep and
how to improve sleep quality
for our health & well-being
demonstrations and label reading exercises) (15), motivation and
goal setting skills (16), and mindfulness techniques (17) (see
Table 3). Each week, for 12 weeks, participants attended a 6-h
session at TMC, where content and practical exercises from each
of the five modules was delivered by an exercise physiologist,
dietitian and/or a GP (see Table 3 for examples). Participants
were provided with a printed booklet each week outlining content
for that session (e.g., psychoeducation theory, exercise diagrams,
step by step recipes, label reading guidelines) with areas to take
notes and complete tasks such as goal setting activities and
shopping lists. Table 4 provides an example program day.
HBHM Version 2 (2016)—Pilot Data
Characteristics
Fifteen patients were referred to the pilot program, five patients
declined to participate and ten patients were willing to take
part. All participants attended the week 0 and week 12 sessions.
Some of the weekly follow-up sessions were missed due to illness
or other personal commitments with an average attendance
rate of 80%.
Most of the sample was female (n = 8; 80%) with a mean
age of 51.8 years (SD = 12.9 years) (see Table 5). Over half the
sample were unemployed/not working or on a disability pension
(n = 6; 60%). The most common primary DSM-IV psychiatric
diagnosis as reported in the treating psychiatrist referral to the
program was Major Depressive Disorder (MDD) (n = 6; 60%)
followed by Bipolar Affective Disorder (n= 2; 20%), Generalized
Anxiety Disorder (GAD) (n= 1; 10%) and Alcohol Abuse (n= 1;
10%). Psychiatric co-morbidity was common with diagnoses of
Generalized Anxiety Disorder (GAD) (n =3; 30%), Binge Eating
Disorder (n = 1; 10%), Borderline Personality Disorder (n = 1;
10%) and Major Depressive Disorder (n= 1; 10%).
All participants were taking psychotropic medications defined
as an antidepressant, mood stabilizer, second generation
antipsychotic or benzodiazepine. The participant’s primary
medications were agomelatine (n = 2; 25–50 mg/day),
desvenlafaxine (n= 2; 50–100mg/day), fluvoxamine (n= 2; 200–
300 mg/day), paroxetine (n = 1; 20mg), venlafaxine (n= 1; 75
mg/day); escitalopram (n = 1; 40 mg/day); lamotrigine (n = 1;
50mg). On average participants were taking 2.4 (SD = 1.17)
psychotropic medications ranging from 1 to 4 psychotropic
medications. The most common psychotropic medication taken
alongside a primary psychotropic medication were second
generation antipsychotics (e.g., quetiapine, lurasidone; n = 6;
60%) followed by mood stabilizers (n= 4; 40) (see Table 5).
The most common chronic medical conditions self-reported
by participants or as listed in the referral to the program were
hyperlipidaemia (n = 4; 40%), hypertension (n = 3; 30%),
arthritis (n = 3; 30%), Type II Diabetes (n = 3; 20%), sleep
apnoea (n = 2; 20%), and chronic pain/fibromyalgia (n = 2;
20%). Other conditions such as, fatty liver disease (n = 1;
10%), pancreatitis (n = 1; 10%), ulcerative colitis (n = 1;
10%), costochondritis (n = 1; 10%), fructose malabsorption
syndrome (n = 1; 10%), endometriosis (n = 1; 10%), restless leg
syndrome (n = 1; 10%) and hypothyroidism (n = 1; 10%) were
self-reported.
Table 6 presents the anthropometrics of the participants
at week 0 and week 12. The average BMI of the cohort at
week 0 was 36.18 (SD = 4.67) which, according to the World
Health Organization, classes the participants as Obese Class
I. As a cohort, the participants also had impaired glucose
tolerance as evidenced by a fasting glucose test average >
5.5 (mean = 5.57 ± 1.19). The participants’ cholesterol and
BP were normal, most likely due to their use of prescribed
statins and hypertensive medications. According to DASS
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TABLE 4 | An example HBHM (version 2) program day.
Time Key component
9.30–10.00 a.m. Greeting and brief overview of the session
• Includes questions about the previous week or
any updates
10.00–10.45 a.m. Exercise theory and practice with an Exercise
physiologist
• Education session: Yoga theory and benefits
• Practical component: Yoga
10.45–11.00 a.m. Tea break
11.00–12.15 p.m. Lifestyle psychoeducation with dietitian/GP
• Education session: Cortisol—The “good” and “bad”
of stress
• Brainstorming strategies to manage stress
12.15–1.00 p.m. Lunch
• Practical component: Cooking demonstration with
dietitian (example recipe: stuffed capsicums, roast
vegetable and grain salad)
1.00–2.00 p.m. Nutrition theory with dietitian
• The evidence, benefits and “how to” of a
Mediterranean diet
2.00–2.15 p.m. Tea break
2.15–2.45 p.m. Mindfulness meditation
• Practical session: Mindfulness based
stress reduction
2.45–3.30 p.m. Motivation and goal setting –
• Identify goal for the week using SMART guidelines
measurement at week 0, participants had low to moderate
levels of depression (mean = 8.30; SD = 4.69), anxiety
(mean = 6.0; SD = 4.64), and stress (mean = 8.70; SD = 4.24)
symptomatology (see Table 6).
Participant Goals
The most common goal was to increase exercise levels and fitness
(n = 5; 50%) followed by eat healthier (n = 4; 40%), reduce
sugar intake (n = 3; 30%) and lose weight (n = 3; 30%). On
average the participants rated their readiness to change as 7.75
(SD = 2.12) with ratings ranging from 3 to 10. Thus, as a whole
the participants were very ready to make change.
Outcome Data
The cohort had a significant weight loss over the 12 weeks with an
average loss of 2 kg, t(9) = 2.75, p= 0.023. Weight change ranged
from a +1.4 kg weight gain to a −6 kg weight loss. Along with
weight loss, there was also a significant reduction in abdominal
circumference (mean = 2.55 cm) and a drop in BMI of almost
one point (mean = 0.96 kg/m2), t(9) = 2.32, p = 0.046 and
t(9) = 0.96, p = 0.019. No significant changes in participant’s
blood levels or anthropometrics were found. Additionally, no
significant changes in participant’s mental health was found on
the DASS when comparing week 0 to week 12 (see Table 6).
Participant’s readiness to change (mean = 7.75; SD = 2.12) was
not correlated with change in BMI, abdominal circumference, or
weight change at end of the program, r = −0.615, p = 0.105,
r =−0.205, p= 0.626, and r = −0.692, p= 0.057, respectively.
TABLE 5 | HBHM (version 2) Baseline characteristics (n = 10).
Characteristic Mean ± SD/ n (%)
Age 51.80 ± 12.93
Female 8 (80%)
Primary psychiatric diagnosis
Major Depressive Disorder 6 (60%)
Bipolar Affective Disorder 2 (20%)
Generalized Anxiety Disorder 1 (10%)
Alcohol Dependence 1 (10%)
Primary psychotropic medication*
Antidepressant 9 (90%)
Mood stabilizer 1 (10%)
Other psychotropic medications*
Second generation antipsychotic 6 (60%)
Mood stabilizer 4 (40%)
Antidepressant 2 (20%)
Benzodiazepine 2 (20%)
*Participants could be taking more than one psychotropic medication (mean = 2.4;
SD = 1.17).
DISCUSSION
This pilot study found that an integrated 12-week lifestyle
program was associated with significant weight loss in patients
with a mental illness. We found a mean 2 kg weight loss
and a drop in BMI of almost one point across the course
of 12 weeks. Our findings are in line with a recent meta-
analysis which found lifestyle interventions were superior to
treatment-as-usual in producing weight loss in patients with a
serious mental illness (18). This improvement in anthropometric
measures is clinically significant when considering the challenges
experienced by patients with a mental illness in maintaining
physical and mental wellness.
No beneficial effect on participant’s mental health was found
despite incorporating meditation, goal setting, mindfulness, and
motivation modules, which was a distinguishing feature of the
program. This finding was surprising given mindfulness-based
therapies have been consistently related to improvements in
mood and anxiety in clinical populations (17). However, a recent
lifestyle intervention for residential patients with a seriousmental
illness also found no positive changes on psychosocial outcomes
(19). This suggests that it is challenging to get a beneficial effect
on psychosocial outcomes while attempting to improve physical
and mental health outcomes simultaneously. The addition of
individual psychotherapy alongside participation in the program
might be warranted and the incorporation of other evidence-
based psychotherapies such as, cognitive behavioral therapy
should be considered in future versions of the program. Future
iterations of the program should also incorporate quality of life
assessments and measures of psychosocial functioning to more
accurately assess the program’s potential benefit.
Alternatively, the modest effect on participant’s mental health
during the program could be due to the low baseline levels
of depression, anxiety, and stress (as captured on the DASS),
and hence had less scope for improvement. Furthermore, when
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TABLE 6 | HBHM (version 2) program (n = 10) outcome data (week-0 to
week-12).
Outcome Week 0 Week 12 Paired
t-test
Weight (kgs) 100.3 ±
9.79
98.3 ± 9.72 t = 2.75
p = 0.023*
Abdominal circumference
(cm)
119.95 ±
12.69
117.40 ±
12.47
t = 2.32
p = 0.046*
BMI 36.18 ±
4.67
35.22 ±
4.73
t = 2.86
p = 0.019*
Waist to hip ratio 0.96 ± 0.08 0.96 ± 0.07 t = −0.362
p = 0.726
Systolic blood pressure 122.67 ±
15.23
130.25 ±
14.82
t = −1.12
p = 0.300
Diastolic blood pressure 79.67 ±
11.59
80.88 ±
10.27
t = 0.144
p = 0.890
Fasting glucosea 5.57 ± 1.19 5.72 ± 1.03 t = −0.44,
p = 0.682
HDL cholesterola 1.21 ±.26 1.24 ±.21 t = 0.500,
p = 0.705
LDL cholesterola 2.61 ±.98 3.30 ± 1.20 t = −2.00,
p = 0.295
Total fasting cholesterola 5.34 ± 1.41 5.95 ± 1.20 t = −2.61,
p = 0.080
Triglyceridesa 2.30 ±.57 2.13 ±.30 t = −0.33,
p = 0.761
DASS 21—Depression
score
8.30 ± 4.69 9.70 ± 5.44 t = −0.87,
p = 0.408
DASS 21—Anxiety score 6.00 ± 4.64 5.50 ± 5.10 t = 0.75,
p = 0.475
DASS 21—Stress score 8.70 ± 4.24 8.50 ± 4.72 t = 0.38,
p = 0.716
*p < 0.05.
aMissing data on week 12 (n = 4).
identifying goals of the program, not one participant mentioned
they would like to improve their mental health. Rather the goals
reported by participants were orientated toward improving their
eating habits and losing weight. The incorporation of behavioral
and psychological components (such as mindful eating and goal
setting) is deemed to benefit the delivery and engagement of the
program contents and helped to adhere to recommendations in
order to achieve the weight loss results.
A major limitation to the current study was the small
sample size and that it was uncontrolled. A larger sample
with an appropriate control is required to assess the program
effectiveness and allow for further feedback from participants
to fine-tune the program. We also recognize that more work
is needed to refine the delivery and format structure in respect
to determining the best application of the program given costs
and time constraints. In particular, the exercise component
should aim to provide at least 90min of moderate-to-vigorous
exercise per week, as this intensity has been shown to improve
psychiatric symptoms in patients with a serious mental illness
(20). Furthermore, closer monitoring of physical activity outside
of the program should be employed in order to assess the
translational impact of the program to the home environment.
While the 12-week program was comprehensive, it also has
its drawback in terms of time requirements, and a 6-h once per
week delivery is quite intensive for people with a mental illness. A
follow-up should also be employed to determine whether weight
loss results are maintained, continued, or regained following the
cessation of the program.
There is the potential to restructure the program to have a
blend of face-to-face delivery with online components, and even
the use of a mobile phone app. This would provide flexibility, less
demands on time, and less financial burden for the participants.
Weight loss in this population is extremely challenging as
many patients have co-morbid medical conditions, and limited
social and economic resources. Thus, facilitating weight loss
using strategies that can be implemented into everyday life is
paramount to success. In addition, implementing and assessing
strategies which prevent the all too frequent “weight regain”
phenomena is crucial (21).
As 60% of the sample were taking second generation
antipsychotics, the results are encouraging for metabolically
vulnerable patients. However, it is important to note, that the
results cannot be generalized to participants with a serious
mental illness as the current pilot did not include participants
with schizophrenia who are at the most risk of developing
MetS. It is unclear how this particular patient population would
engage with this intervention. In conclusion, the pilot data
of the HBHM program found significant benefits in reducing
weight and abdominal obesity, with the potential to achieve
substantial health benefits for patients with a mental illness and
co-morbid metabolic syndrome. Study replication is required
using a controlled design in a larger sample over a longer
time period.
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